Cambridge Investment Research Advisors, Inc. Biocryst Pharmaceuticals Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$27.1 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $329,032 - $562,428	-28,463 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$11.18 - $15.46 $1,118 - $1,546	100 Added 0.35%	28,463 $394,000
Q3 2021 Nov 02, 2021	SELL	$14.21 - $17.65 $69,657 - $86,520	-4,902 Reduced 14.74%	28,363 $407,000
Q2 2021 Aug 10, 2021	SELL	$9.5 - $17.24 $142,918 - $259,358	-15,044 Reduced 31.14%	33,265 $525,000
Q1 2021 May 07, 2021	BUY	$7.37 - $13.61 $45,060 - $83,211	6,114 Added 14.49%	48,309 $491,000
Q4 2020 Feb 04, 2021	BUY	$3.37 - $8.61 $20,927 - $53,468	6,210 Added 17.26%	42,195 $314,000
Q3 2020 Oct 29, 2020	SELL	$3.43 - $5.53 $59,750 - $96,332	-17,420 Reduced 32.62%	35,985 $123,000
Q2 2020 Jul 27, 2020	BUY	$1.9 - $5.61 $101,469 - $299,602	53,405 New	53,405 $254,000

Others Institutions Holding BCRX

# of Institutions

257

Shares Held

173M

Call Options Held

397K

Put Options Held

444K

Black Rock Inc. New York, NY

20M
Shares

$158 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

18.8M
Shares

$149 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

12.6M
Shares

$99.6 Million
1.06% of portfolio
State Street Corp Boston, MA

9.35M
Shares

$74 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.83M
Shares

$69.9 Million
4.25% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.47B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account